ADC Therapeutics S.A. (ADCT)
NYSE·Healthcare·Biotechnology
$1.07
-4.05%
Mkt Cap $136.09M
Analyst Ratings
Buy
4
Hold
1
Sell
0
Price Target (9 analysts)
$3.50
Range $2.00 – $5.00
Implied Upside
+227.1%
Consensus $3.50 vs current $1.07
NYSE·Healthcare·Biotechnology
$1.07
-4.05%
Mkt Cap $136.09M
Buy
4
Hold
1
Sell
0
Price Target (9 analysts)
$3.50
Range $2.00 – $5.00
+227.1%
Consensus $3.50 vs current $1.07